Literature DB >> 19066779

Synergism between monodesbutyl-benflumetol and artemisinin in Plasmodium falciparum in vitro.

Gernot Müller1, Gunther Wernsdorfer, Jeeraphat Sirichaisinthop, Peter Starzengruber, Kanungnit Congpuong, Walther H Wernsdorfer.   

Abstract

The sensitivity to artemisinin, monodesbutyl-benflumetol (DBB) and a 1:1 m/m combination of the two compounds was successfully investigated on 34 fresh isolates of Plasmodium falciparum. On a molar basis the combination was most active, followed by DBB and artemisinin. The geometric mean concentrations effecting full inhibition (GMCOC) were 49.25 nM for the combination, 279.12 nM for DBB, and 494.05 for artemisinin. The difference between the efficacy of the combination and that of its components was highly significant. Interaction between artemisinin and DBB showed moderate synergism at the EC(50) and strong synergism at EC(90) and EC(99). The individual parasite isolates showed a significant inverse correlation between the ECs and the degree of synergism. Positive specific pharmacodynamic interaction was therefore most marked in isolates with reduced sensitivity against artemisinin and DBB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066779     DOI: 10.1007/s00508-008-1034-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  8 in total

1.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

2.  Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand.

Authors:  H Noedl; T Allmendinger; S Prajakwong; G Wernsdorfer; W H Wernsdorfer
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

4.  Synergism of benflumetol and artemether in Plasmodium falciparum.

Authors:  M Hassan Alin; A Björkman; W H Wernsdorfer
Journal:  Am J Trop Med Hyg       Date:  1999-09       Impact factor: 2.345

5.  Comparative study on the in vitro activity of lumefantrine and desbutyl-benflumetol in fresh isolates of Plasmodium vivax from Thailand.

Authors:  Daniela K Pirker-Krassnig; Gunther Wernsdorfer; Jeeraphat Sirichaisinthop; Chaiporn Rojanawatsirivet; Herwig Kollaritsch; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2004       Impact factor: 1.704

6.  In vitro interaction between artemisinin and chloroquine as well as desbutyl-benflumetol in Plasmodium vivax.

Authors:  Leila Kyavar; Chaiporn Rojanawatsirivet; Herwig Kollaritsch; Gunther Wernsdorfer; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

Review 7.  Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices.

Authors:  Shunmay Yeung; Wirichada Pongtavornpinyo; Ian M Hastings; Anne J Mills; Nicholas J White
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

Review 8.  Chemical studies on qinghaosu (artemisinine). China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.

Authors: 
Journal:  J Tradit Chin Med       Date:  1982-03       Impact factor: 0.848

  8 in total
  2 in total

1.  Desbutyl-lumefantrine is a metabolite of lumefantrine with potent in vitro antimalarial activity that may influence artemether-lumefantrine treatment outcome.

Authors:  Rina P M Wong; Sam Salman; Kenneth F Ilett; Peter M Siba; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

2.  Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania.

Authors:  Manase Kilonzi; Omary Minzi; Ritah Mutagonda; Vito Baraka; Philip Sasi; Eleni Aklillu; Appolinary Kamuhabwa
Journal:  Malar J       Date:  2020-02-11       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.